Sign In
Buy PFS
$21.54
-0.710 (-3.19%)
At Close: Jun 03, 2026
Provident Financial (PFS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
08:06pm, Tuesday, 29'th Oct 2024
Although the revenue and EPS for Provident Financial (PFS) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare wi
Provident Financial (PFS) Lags Q3 Earnings and Revenue Estimates
07:20pm, Tuesday, 29'th Oct 2024
Provident Financial (PFS) came out with quarterly earnings of $0.36 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago.
Provident Financial Services, Inc. Reports Third Quarter Earnings and Declares Quarterly Cash Dividend
05:00pm, Tuesday, 29'th Oct 2024
ISELIN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $46.4 million, or $0.36 per basic and diluted share for the thr
HONG KONG , Oct. 16, 2024 /PRNewswire/ -- Akeso Biopharma (9926.HK) (" Akeso", the "Company" ) announced positive results in progression-free survival (PFS) and overall survival (OS) from its Phase
Provident Bank Announces $88,000 in Grants to Nine New Jersey Non-Profit Organizations
08:00am, Monday, 16'th Sep 2024
Funding is provided through the bank's Community Partnership Program Funding is provided through the bank's Community Partnership Program
Readers Identify 25 Ideal July Dividend Buys Out Of 37 Picks
11:36am, Tuesday, 20'th Aug 2024
Before July 31, 2024, my REaders mentioned 38 equities in their comments on my articles. Some bad-news investments (ROgues) mixed with (mostly) FAvorites. Thus, readers commented about the ReFa/Ro. Te
New Pacific Metals Announces Filing of NI 43-101 PFS Technical Report for the Silver Sand Project
04:00am, Thursday, 08'th Aug 2024
VANCOUVER, BC, Aug. 8, 2024 /PRNewswire/ - New Pacific Metals Corp. (TSX: NUAG) (NYSE-A: NEWP) ("New Pacific" or the "Company") is pleased to report the filing of an independent Pre-Fea
Don't Buy AI Stocks, Buy The Best Dividend Total Return Stocks
03:29am, Thursday, 01'st Aug 2024
I have a diversified portfolio of stocks, funds, and bonds. My stocks are primarily dividend paying value stocks. One can find dividend stocks with superior estimated total returns by comparing their
Provident Bank Welcomes Leonardo Ramos As Vice President, CRA Officer
08:00am, Wednesday, 31'st Jul 2024
ISELIN, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Provident Bank , a leading New Jersey-based financial institution, is pleased to welcome Leonardo Ramos as Vice President, Community Reinvestment Act
Provident Financial Services, Inc. (PFS) Q2 2024 Earnings Call Transcript
01:40pm, Friday, 26'th Jul 2024
Provident Financial Services, Inc. (NYSE:PFS ) Q2 2024 Results Conference Call July 26, 2024 10:00 AM ET Company Participants Adriano Duarte - Head of Investor Relations Tony Labozzetta - President an
Provident Financial (PFS) Reports Q2 Earnings: What Key Metrics Have to Say
08:35pm, Thursday, 25'th Jul 2024
Although the revenue and EPS for Provident Financial (PFS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wa
ISELIN, N.J., July 25, 2024 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported a net loss of $11.5 million, or $0.11 per basic and diluted share for the thr
BriaCell Quadruples Progression Free Survival (PFS) in Patient with “Eye-Bulging” Metastatic Breast Cancer
07:56am, Thursday, 18'th Jul 2024
PHILADELPHIA and VANCOUVER, British Columbia, July 18, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bio
Strength Seen in Provident Financial (PFS): Can Its 5.7% Jump Turn into More Strength?
12:45pm, Friday, 12'th Jul 2024
Provident Financial (PFS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength d
FDA Approves Genentech's Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss
01:00am, Friday, 05'th Jul 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug Administration (FDA) has approved the Vabysmo®
